ストックスクリーナーアプリを入手
2.4302
0.40%
-0.0098
InspireMD Inc. (NSPR) 最新ニュース
What makes InspireMD Inc. stock price move sharplyConsistent Growth Alert - Newser
How MSGS stock compares to its top competitorsIs InspireMD Inc. stock undervalued or overvalued nowRapid market gains - jammulinksnews.com
What drives InspireMD Inc. stock priceUnprecedented profit potential - PrintWeekIndia
What analysts say about InspireMD Inc. stockRapid wealth multiplication - Autocar Professional
Is InspireMD Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
InspireMD Inc. Stock Analysis and ForecastAccelerated capital growth - jammulinksnews.com
How InspireMD Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
InspireMD to Announce Second Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Schedules Release of Second Quarter 2025 Financial Results and Conference Call - Quiver Quantitative
InspireMD Q2 Earnings: Stroke Prevention Tech Leader Hosts Call August 5 at 8:30 AM ET - Stock Titan
Brown Advisory Inc. Takes $27,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid Stent - MSN
InspireMD Launches CGuard Prime Carotid Stent System in the U.S. - MSN
Why InspireMD Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
InspireMD Launches CGuard Prime Stent in U.S. Market - The Globe and Mail
InspireMD launches CGuard Prime carotid stent in US after FDA approval By Investing.com - Investing.com South Africa
InspireMD Launches Carotid Stent System for the Preventing Strokes - Diagnostic and Interventional Cardiology
InspireMD stock rises after US commercial launch of carotid stent system - Investing.com Nigeria
InspireMD stock rises after US commercial launch of carotid stent system By Investing.com - Investing.com South Africa
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - The Manila Times
InspireMD launches CGuard Prime carotid stent in US after FDA approval - Investing.com
NSPR launches CGuard Prime in U.S.; 8-K filed with Exhibit 99.1 | NSPR SEC FilingForm 8-K - Stock Titan
1.27%
大文字化:
|
ボリューム (24 時間):